SCHEMBL7205924

SCHEMBL7205924

O=S(=O)(O)c1ccc(Br)c(Br)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
HSD17B10 Q99714 5/20 0.47
LMNA P02545 1/20 0.46
TSHR P16473 3/20 0.44
NT5E P21589 1/20 0.44
CA2 P00918 5/20 0.43
CA1 P00915 4/20 0.43
CA9 Q16790 3/20 0.43
CA12 O43570 2/20 0.43
CA7 P43166 2/20 0.43
CA14 Q9ULX7 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
CA4 P22748 1/20 0.43
CA6 P23280 1/20 0.43
CA5A P35218 1/20 0.43
CA5B Q9Y2D0 1/20 0.43
KDM4E B2RXH2 3/20 0.42
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
FLT1 P17948 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8925676 0.98 ALDH1A1 (0.45) ALDH1A1HSD17B10LMNATSHRNT5E
SCHEMBL6915816 0.98 ALDH1A1 (0.45) ALDH1A1HSD17B10LMNATSHRNT5E
SCHEMBL6915364 0.98 ALDH1A1 (0.45) ALDH1A1HSD17B10LMNATSHRNT5E
SCHEMBL6909137 0.98 ALDH1A1 (0.45) ALDH1A1HSD17B10LMNATSHRNT5E
SCHEMBL6909521 0.98 ALDH1A1 (0.45) ALDH1A1HSD17B10LMNATSHRNT5E
SCHEMBL6915395 0.98 ALDH1A1 (0.45) ALDH1A1HSD17B10LMNATSHRNT5E
SCHEMBL6917507 0.98 ALDH1A1 (0.45) ALDH1A1HSD17B10LMNATSHRNT5E
SCHEMBL6909142 0.98 ALDH1A1 (0.45) ALDH1A1HSD17B10LMNATSHRNT5E
SCHEMBL6915391 0.98 ALDH1A1 (0.45) ALDH1A1HSD17B10LMNATSHRNT5E
SCHEMBL10424119 0.84 ALDH1A1 (0.55) ALDH1A1HSD17B10LMNATSHRNT5E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4820831-A Process for preparing 4,4'-dihydroxydiphenyl sulfone having high purity KONISHI CHEMICAL INDUSTRY CO., LTD. (JP) 1989-04-11 US claimed
US-20200323986-A1 HYDROPHOBIC ARENESULFONATE SALTS THERACAINE LLC 2020-10-15 US disclosed
US-20200323834-A1 HYDROPHOBIC ACID ADDITION SALTS AND PHARMACEUTICAL FORMULATIONS THEREOF THERACAINE LLC 2020-10-15 US disclosed
EP-3703686-A1 HYDROPHOBIC ARENESULFONATE SALTS Theracaine LLC (US) 2020-09-09 EP disclosed
EP-3704123-A1 HYDROPHOBIC ACID ADDITION SALTS AND PHARMACEUTICAL FORMULATIONS THEREOF Theracaine LLC (US) 2020-09-09 EP disclosed
EP-0905202-B1 PHOTOSTABILIZED CYANINE DYES AND OPTICAL RECORDING MEDIUM TDK CORP (JP) 2003-03-19 EP disclosed
EP-0841340-B1 SUBSTITUTED BENZENEDITHIOL-METAL COMPLEXES SUMITOMO SEIKA CHEMICALS (JP) 2002-06-19 EP disclosed
US-6071672-A QUATERNARY CYANINE DYE SALT WITH SUBSTITUTED BENZENEDITHIOL METAL COMPLEX ANION; COMPACT DISKS TDK CORPORATION (JP) 2000-06-06 US disclosed
US-5959152-A REACTING 3,4-DIBROMOBEZENESULFONYL CHLORIDE WITH AN AMINE OR AN AROMATIC HYDROCARBON TO FORM A SULFONE OR SULFONAMIDE; REACTING PRODUCT WITH SODIUM HYDROSULFIDE TO FORM DIMERCAPTAN SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 1999-09-28 US disclosed
EP-0905202-A1 PHOTOSTABILIZED CYANINE DYES AND OPTICAL RECORDING MEDIUM TDK Corporation (JP) 1999-03-31 EP disclosed
US-5856520-A OPTICAL RECORDING MEDIA SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 1999-01-05 US disclosed
EP-0841340-A1 SUBSTITUTED BENZENEDITHIOL-METAL COMPLEXES SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 1998-05-13 EP disclosed
US-4820831-A Process for preparing 4,4'-dihydroxydiphenyl sulfone having high purity KONISHI CHEMICAL INDUSTRY CO., LTD. (JP) 1989-04-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200323834-A1 HYDROPHOBIC ACID ADDITION SALTS AND PHARMACEUTICAL FORMULATIONS THEREOF SLCO4C1, ABCB11, SLCO1B1 ALDH1A1 389/4885HSD17B10 92/4885LMNA 4521/4885
US-20200323986-A1 HYDROPHOBIC ARENESULFONATE SALTS ARSA, SLC26A3, ABCB11 ALDH1A1 928/4885HSD17B10 257/4885LMNA 4428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.